Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-25

Clinical Trial Update: Phase II Combination Steroid and Anti-VEGF for Persistent DME [Phase 2]

View source ↗

Summary

Phase II trial update on a combination therapy of steroids and anti-VEGF for persistent diabetic macular edema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • steroid and anti-VEGF combination

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2018-09-25